STOCK TITAN

LeMaitre to Participate in the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference

LeMaitre (Nasdaq: LMAT) announced that its management will participate in investor meetings at the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference on Tuesday, August 11, 2026.

(Neutral)
(Neutral)
Tags

LeMaitre (Nasdaq: LMAT) announced that its management will participate in investor meetings at the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference on Tuesday, August 11, 2026. The event will be held in a virtual format.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.
Argus Aug 7 session
+0.78% close to close Open Argus
Details

News Market Reaction – LMAT

In the Aug 7 session, LMAT gained 0.78%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

Recent records showed Net Selling, including a 27,881-share sale by George W LeMaitre. Against that ...
Analysis

Recent records showed Net Selling, including a 27,881-share sale by George W LeMaitre. Against that backdrop, this scheduling notice supplied no reported operating or financial update; conference commentary remained the key item to monitor.

Key Figures

Conference edition: 11th annual Investor meetings date: August 11, 2026
Conference edition
11th annual
Needham Virtual MedTech & Diagnostics 1x1 Conference
Investor meetings date
August 11, 2026
Needham Virtual MedTech & Diagnostics 1x1 Conference

Historical Context

5 past events · Latest: Jul 14
5 events
  1. Jul 14

    Earnings date notice

    24h Move
    +2.0%

    Announced Q2 2026 results release date and conference call schedule

  2. May 20

    Investor conferences

    24h Move
    -1.9%

    Announced participation in two June healthcare investor conferences

  3. May 07

    Healthcare conference

    24h Move
    +0.0%

    Scheduled management presentation at the Bank of America conference

  4. May 05

    Q1 earnings report

    24h Move
    -1.6%

    Reported higher sales, margins, operating income, EPS, and cash balance

  5. Apr 14

    Earnings date notice

    24h Move
    -2.2%

    Announced Q1 2026 results release date and conference call schedule

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

BURLINGTON, Mass., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will hold investor meetings at the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference on Tuesday, August 11, 2026.

About LeMaitre

LeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at www.lemaitre.com.

Contact:
Sandra Millar
LeMaitre Vascular, Inc.
+1-781-425-1686
smillar@lemaitre.com


FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will LeMaitre (LMAT) attend the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference?

LeMaitre management is scheduled to hold investor meetings on Tuesday, August 11, 2026. According to LeMaitre, these meetings will take place during the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference, which is being held in a fully virtual format.

What is the purpose of LeMaitre (LMAT) participating in the Needham Virtual MedTech & Diagnostics 1x1 Conference 2026?

LeMaitre management will participate to hold investor meetings at the conference. According to LeMaitre, these 1x1 meetings at the 11th Annual Needham Virtual MedTech & Diagnostics event facilitate direct discussions with investors in a virtual setting on August 11, 2026.

Is LeMaitre's appearance at the 2026 Needham MedTech & Diagnostics 1x1 Conference in person or virtual?

LeMaitre will attend the conference in a virtual format. According to LeMaitre, management will conduct investor meetings online as part of the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference on August 11, 2026.

Who from LeMaitre (NASDAQ: LMAT) will be at the Needham Virtual MedTech & Diagnostics 1x1 Conference in August 2026?

LeMaitre stated that its management team will hold investor meetings at the event. According to LeMaitre, company management will participate in the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference on August 11, 2026, in a virtual environment.

How might LeMaitre's (LMAT) participation in the Needham Virtual MedTech & Diagnostics 1x1 Conference impact investors?

Participation provides investors a scheduled opportunity to meet directly with LeMaitre management. According to LeMaitre, these virtual 1x1 meetings on August 11, 2026, are designed for investor interaction, though no specific financial or strategic updates were disclosed in the announcement.

Keep reading